User profiles for Mitchell A. Avery

Mitchell A. Avery

Professor of Medicinal Chemistry, Emeritus
Verified email at olemiss.edu
Cited by 11497

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ–modulating activity

…, P Desai, M Pravenec, N Qi, J Wang, MA Avery… - …, 2004 - Am Heart Assoc
The metabolic syndrome is a common precursor of cardiovascular disease and type 2 diabetes
that is characterized by the clustering of insulin resistance, dyslipidemia, and increased …

Stereoselective total synthesis of (+)-artemisinin, the antimalarial constituent of Artemisia annua L

MA Avery, WKM Chong… - Journal of the American …, 1992 - ACS Publications
A 10-step stereoselective total synthesis of the antimalarial cadinanesesquiterpene (+)-artemisinin
(1) is described. Elaboration of (/?)-(+)-pulegone to the known sulfoxide 11 was …

Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor

…, E Schaeffeler, E Efimova, BA Avery, MA Avery… - Molecular …, 2005 - ASPET
Artemisinin drugs are of utmost importance in the treatment of malaria, because they represent
the sole class of therapeutically used antimalarial drugs to which malaria parasites have …

Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery

…, MA Repka, S Maddineni, AG Chittiboyina, MA Avery… - Aaps Pharmscitech, 2010 - Springer
The objective of the present research was to evaluate the physicochemical characteristics of
berberine chloride and to assess the complexation of drug with 2-hydroxypropyl-β-…

Type 2 diabetes and oral antihyperglycemic drugs

MA Avery, CS Mizuno, AG Chittiboyina… - Current medicinal …, 2008 - ingentaconnect.com
Type II diabetes is a heterogeneous disease where environment and genetics are important
factors for the expression of the disease. The high cost for treating complications of diabetes …

Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5 …

N Singh, G Chevé, MA Avery… - Current pharmaceutical …, 2007 - ingentaconnect.com
The 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway for isoprenoid biosynthesis has
come under increased scrutiny as a target for novel antimalarial, antibacterial and herbicidal …

Nigellidine-4-O-sulfite, the First Sulfated Indazole-Type Alkaloid from the Seeds of Nigella sativa

Z Ali, D Ferreira, P Carvalho, MA Avery… - Journal of natural …, 2008 - ACS Publications
The rare indazole-type alkaloid nigellidine (2) is accompanied by its 4-O-sulfite (4) in the
seeds of Nigella sativa. Compound 4 may represent the true natural product leading to …

Structure− Activity Relationships of the Antimalarial Agent Artemisinin. 8. Design, Synthesis, and CoMFA Studies toward the Development of Artemisinin-Based Drugs …

MA Avery, KM Muraleedharan, PV Desai… - Journal of Medicinal …, 2003 - ACS Publications
Artemisinin (1) and its analogues have been well studied for their antimalarial activity. Here
we present the antimalarial activity of some novel C-9-modified artemisinin analogues …

Giardiasis: Recent Progress in Chemotherapy and Drug Development (Hot Topic: Anti-Infective Agents Executive Editors: Mitchell A. Avery/Vassil St.) Georgiev

T Mineno, MA Avery - Current pharmaceutical design, 2003 - ingentaconnect.com
Giardiasis is a protozoal disease infecting 200 million people throughout the world.
Giardiasis is widespread primarily in developing countries. Infections are correlated with poor …

[HTML][HTML] Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials

…, M Alvim-Gaston, MA Avery - Current pharmaceutical …, 1999 - books.google.com
This review covers developments in relation to artemisinin-based antimalarial agents.
Topics covered include a brief introduction to the history and treatment of malaria, and more …